WHO Recommends Two More COVID-19 Therapies
The WHO has recommended the use of two more COVID-19 drugs, Baricitinib and Sotrovimab, for both mild-to-moderate and severe disease.
Read More »
Treatments
Two COVID-19 Antiviral Pills Granted EUA
This week, the FDA granted EUA for two COVID-19 oral antiviral pills, which will be added as a second treatment protocol for COVID-19. Up until now, monoclonal antibodies have been the only authorized treatment for patients with COVID-19.
Read More »Sotrovimab and the Omicron Variant
Preliminary laboratory tests have indicated that Sotrovimab performs best against the Omicron variant. This may be due to the fact that Sotrovimab was designed to target a part of the spike protein that did not mutate between previous coronavirus strains and the Omicron variant.
Read More »Role of RNAaemia and the Immunopathology of Moderate-to-Severe COVID
A Viewpoint article published in The Lancet Rheumatology proposed that different presentations of COVID-19 may require varied approaches for treatment.
Read More »